Stanley ER, Chitu V. CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol.
2014;6(6):a021857. doi:10.1101/cshperspect.a021857.
Richardsen E, Uglehus RD, Johnsen SH, Busund LT. Macrophage-colony stimulating factor (CSF1) predicts
breast cancer progression and mortality. Anticancer Res. 2015;35(2):865-874.
Nandi S, Gokhan S, Dai X-M, et al. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct
developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev
Biol. 2012;367(2):100-113.
Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49-61.
Zhu Y, Knolhoff BL, Meyer MA, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and
improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res.
2014;74(18):5057-5069.
Yang L, Wu Q, Xu L, et al. Increased expression of colony stimulating factor-1 is a predictor of poor
prognosis in patients with clear-cell renal cell carcinoma. BMC Cancer. 2015. doi:10.1186/s12885-015-1076-5.
Ries CH, Cannarile MA, Hoves S, et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody
reveals a strategy for cancer therapy. Cancer Cell. 2014;25(6):846-859.
Mitchem JB, Brennan DJ, Knolhoff BL, et al. Targeting tumor-infiltrating macrophages decreases
tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res.
2012;73(3):1128-1141.
Neubert NJ, Schmittnaegel M, Bordry N, Nassiri S, Wald N, Martignier C, Tillé L, Homicsko K, Damsky W,
Maby-El Hajjami H, Klaman I. T cell–induced CSF1 promotes melanoma resistance to PD1 blockade. Science
translational medicine. 2018;10(436):eaan3311.